Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CET

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
11/17 MERCK : Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Pla..
11/16 MERCK KGAA : Release according to Article 26, Section 1 of the WpHG [the German ..
11/15 Bayer hires new blood to stem 'Amazon effect' in consumer health
11/15 MERCK : EMD Serono Receives FDA Approval for New GONAL-f RFF Redi-ject Pen
11/13 MERCK : Receives FDA Approval for New GONAL-f® Prefilled Pen
11/13 MERCK : and International Diabetes Federation Partner to Help Address Global Typ..
11/13 MERCK KGAA : Release according to Article 26, Section 1 of the WpHG [the German ..
11/10 MERCK : Darmstadt, Germany, Explores Digital Transformations at Displaying Futur..
11/09 MERCK : Findings in Osteoarthritis Reported from Merck KGaA
11/09 MERCK : Lupus Foundation of America and EMD Serono Launch The ALPHA Project to I..
More news
News from SeekingAlpha
11/13 Orexigen Contrave up 10% on Contrave distribution deal with Merck KGaA for La..
11/13 Merck KGaA ADR 2017 Q3 - Results - Earnings Call Slides
11/09 Merck KGaA (MKGAF) Q3 2017 Results - Earnings Call Transcript
11/09 Merck KGaA reports Q3 results
10/27 JUNIPER PHARMACEUTICALS : A High Risk, High Reward Women's Health Play
Financials (€)
Sales 2017 15 350 M
EBIT 2017 3 282 M
Net income 2017 1 633 M
Debt 2017 9 829 M
Yield 2017 1,39%
P/E ratio 2017 20,83
P/E ratio 2018 20,49
EV / Sales 2017 1,40x
EV / Sales 2018 1,25x
Capitalization 11 704 M
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 109 €
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
Michael Fletterich Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA-8.66%13 796
ABBVIE49.49%149 223
KYOWA HAKKO KIRIN CO LTD33.75%11 130
JAZZ PHARMACEUTICALS PLC22.78%8 026
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD42.96%6 074
CONVATEC GROUP-12.18%5 289